Eurofins Pharma Discovery Services

Eurofins Pharma Discovery Services has supported drug discovery research for more than 40 years, recognized as an industry leader offering the largest and most diverse portfolio of standard and custom in vitro safety and pharmacology assays for drug screening and profiling. The company's broader portfolio spans more than 3,500 drug discovery services and 1,800 products, including in vitro assays, cell-based phenotypic assays, safety pharmacology and efficacy testing, ADME-Tox, chemistry, and custom proteins and assay development for targets such as GPCRs, kinases, ion channels and nuclear hormone receptors.